← Back
Pharmacology I · Exam 3 · Class of 2028

Side Effects & Monitoring

120 entries across the Exam 3 lectures, each citing its slide, with black box warnings shaded. Companion to the contraindications and indications charts.

Grouped by class within each lecture; the System column is how a stem gives it to you — “a patient on this drug develops a dry cough” is a respiratory question, not a drug-name question.
Black box warnings come first. The course director ranks them above ordinary adverse effects; 16 rows here carry one and are shaded. Most common systems: Cardiovascular (37), Nervous system (16), Gastrointestinal (12), Electrolytes (11), Metabolic (11), Respiratory (10).
L9 Diuretics and Heart Failure DrugsL10 Antiarrhythmic DrugsL11 Drugs for Pulmonary Infections, Asthma and Chronic Obstructive Pulmonary Disease

Lecture 9 — Diuretics and Heart Failure Drugs 51 entries

Drug or classSide effectsMonitoring & what to watchSystemSource
Loop diuretics
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Volume depletion through reflex mechanisms, with azotemia (a rise in blood urea nitrogen). Excess diuresis can cause hypotension and cardiovascular collapse.Check weight, blood pressure and orthostatic symptoms; check blood urea nitrogen and creatinine.Renal / FluidL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acidBlack box
Volume depletion when given in excess. Added background: furosemide, bumetanide and ethacrynic acid carry an FDA boxed warning (black box) for profound diuresis with water and electrolyte depletion; torsemide carries none.Start at the lowest effective amount and watch fluid status and electrolytes closely.Renal / FluidL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Hypokalemia (potassium loss) with the risk of cardiac arrhythmias.Monitor serum potassium; a potassium-sparing partner or supplement may be added. Highest risk with digoxin.Electrolytes / CardiovascularL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Loss of calcium and magnesium in the urine (hypocalcemia and hypomagnesemia).Monitor magnesium and calcium with long-term use.ElectrolytesL9
slide 13
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Hyponatremia, which can lead to seizures.Monitor serum sodium.Electrolytes / NeurologicL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Hyperglycemia (a diabetogenic effect): low potassium impairs insulin release, catecholamines are released reflexively (alpha-2 decreases insulin release, beta-2 increases glycogenolysis) and peripheral glucose uptake is impaired.Monitor blood glucose in patients with diabetes.MetabolicL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Contraction alkalosis: mild metabolic alkalosis from volume depletion and, mainly, enhanced hydrogen ion secretion.Watch serum bicarbonate.Acid-baseL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Hyperuricemia and gout: less uric acid is excreted and the plasma is concentrated by the lost volume.Ask about a history of gout; a flare may follow starting the drug.Metabolic / MusculoskeletalL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Ototoxicity: damages hair cells in the cochlea (hearing loss). Aminoglycosides potentiate it.Ask about tinnitus or hearing change; avoid combining with other ear-toxic drugs.SensoryL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Allergic reactions: rash and photosensitivity.Counsel on sun protection and to report a rash.DermatologicL9
slide 18
Loop diuretics
furosemide, bumetanide, torsemide, ethacrynic acid
Mild hyperlipidemia (sympathetic activity raises triglycerides) and reflex activation of renin-angiotensin, aldosterone and antidiuretic hormone.Lipids are a minor concern; the reflex activation explains a weakened diuretic effect.Metabolic / EndocrineL9
slide 16
Thiazide diuretics
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Volume depletion with reflex sympathetic activation and increased renin-angiotensin, aldosterone and antidiuretic hormone activity; an acute drop in glomerular filtration rate.Check weight, blood pressure and kidney function.Renal / FluidL9
slide 26
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Hypokalemia (and magnesium loss) and metabolic alkalosis from the contracted extracellular fluid.Monitor potassium; keep it above 4.0 mEq per liter in anyone taking digoxin.Electrolytes / Acid-baseL9
slide 26
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Hyperuricemia and gout.Ask about a history of gout.Metabolic / MusculoskeletalL9
slide 26
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Hyperglycemia (lower glucose tolerance and decreased insulin secretion).Monitor blood glucose in diabetes.MetabolicL9
slide 27
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Hypercalcemia: less calcium is excreted, so serum calcium can rise slightly.Monitor calcium in patients with hypercalcemia or parathyroid disease.ElectrolytesL9
slide 27
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Hyperlipidemia: low-density lipoprotein (LDL) cholesterol rises by roughly 5 to 15 percent.Lipids may be checked during long-term use.MetabolicL9
slide 27
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Allergic skin rashes and photosensitivity.Counsel on sun protection and to report a rash.DermatologicL9
slide 27
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Dizziness, headaches, weakness and restlessness.Ask about these symptoms; they are usually mild.NeurologicL9
slide 27
Thiazide diuretics
chlorothiazide, hydrochlorothiazide, chlorthalidone, metolazone, indapamide
Sexual dysfunction and constipation.Ask directly; patients rarely volunteer sexual symptoms and may stop the drug.Genitourinary / GastrointestinalL9
slide 28
Potassium-sparing diuretics
Potassium-sparing diuretics
amiloride, triamterene
Hyperkalemia: the characteristic adverse effect, and the major difference from other diuretics. Use caution with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and potassium supplements.Monitor serum potassium and kidney function. Added background: warn about potassium-rich foods and salt substitutes, which are usually potassium chloride.ElectrolytesL9
slide 33
Potassium-sparing diuretics
amiloride, triamtereneBlack box
Hyperkalemia, which can be fatal. Added background: FDA boxed warning (black box) for amiloride and triamterene.Check potassium early and regularly; stop and treat a rising level.Electrolytes / CardiovascularL9
slide 33
Potassium-sparing diuretics
amiloride, triamterene
Diabetes: glucose intolerance.Monitor blood glucose in diabetes.MetabolicL9
slide 33
Triamterene
unique effect
Megaloblastic anemia.Watch for fatigue and pallor; a blood count and folate level can be checked.HematologicL9
slide 33
Amiloride
unique effect
Azotemia (a rise in blood urea nitrogen).Monitor kidney function.RenalL9
slide 33
Aldosterone antagonists
Aldosterone antagonists
spironolactone, eplerenone
Hyperkalemia and mild acidosis.Monitor potassium, especially with kidney disease, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.Electrolytes / Acid-baseL9
slide 38
Aldosterone antagonists
spironolactone, eplerenone
Nausea, vomiting and gastrointestinal upset.Take with food if upset occurs.GastrointestinalL9
slide 38
Spironolactone
androgen-receptor effects
Hormonal effects at the androgen (testosterone) receptor. Men: gynecomastia and testicular atrophy. Women: menstrual irregularities (hirsutism is also listed). Gynecomastia occurs in about 10 percent of men in heart failure. Added background (truth over the course wording): the course calls spironolactone a weak partial agonist at the androgen receptor, but in current pharmacology it blocks that receptor (and has some progesterone-like activity). That explains the breast and sexual effects in men and the menstrual changes; hirsutism is not a typical effect, because spironolactone is used to treat hirsutism and acne.Ask about breast tenderness, breast enlargement and menstrual changes; switch to eplerenone if these occur, because it has less effect on androgen receptors.Endocrine / ReproductiveL9
slide 38
Carbonic anhydrase inhibitors
Carbonic anhydrase inhibitors
acetazolamide, dichlorphenamide, methazolamide
Metabolic acidosis (bicarbonate is lost in the urine), unlike the contraction alkalosis of other diuretics.Monitor serum bicarbonate.Acid-baseL9
slide 43
Carbonic anhydrase inhibitors
acetazolamide, dichlorphenamide, methazolamide
Potassium depletion.Monitor serum potassium.ElectrolytesL9
slide 43
Carbonic anhydrase inhibitors
acetazolamide, dichlorphenamide, methazolamide
Drowsiness.Counsel about drowsiness before driving.NeurologicL9
slide 43
Heart failure: diuretics, ACE inhibitors and beta blockers
ACE (angiotensin-converting enzyme) inhibitors
in heart failure
Impairment of renal function (an acute decrease in kidney function).Check creatinine and potassium at the start and after dose changes.RenalL9
slide 56
ACE (angiotensin-converting enzyme) inhibitors
in heart failure
Hypotension, particularly with other blood-pressure-lowering drugs.Check blood pressure; warn about dizziness on standing.CardiovascularL9
slide 56
ACE (angiotensin-converting enzyme) inhibitors
in heart failure
Elevation of serum potassium. A loop diuretic lowers potassium while these raise it, so the balance must be checked.Monitor potassium.ElectrolytesL9
slide 56
ACE (angiotensin-converting enzyme) inhibitors
in heart failure
Cough (dry cough).Ask about a persistent dry cough; an angiotensin receptor blocker avoids it.RespiratoryL9
slide 56
ACE (angiotensin-converting enzyme) inhibitors
in heart failure
Angioedema: swelling of the lips, tongue or throat.Teach the patient to seek urgent help for swelling of the face or tongue; stop the drug.Immunologic / AirwayL9
slide 56
ACE (angiotensin-converting enzyme) inhibitors
in heart failureBlack box
Added background: all angiotensin-converting enzyme inhibitors carry an FDA boxed warning (black box) for fetal toxicity (injury and death of the developing fetus).Confirm the patient is not pregnant before starting; counsel on contraception.Reproductive / FetalL9
slide 56
Beta blockers in heart failure
carvedilol, metoprolol succinate, bisoprolol
Worsening heart failure if started in an unstable patient or raised too fast: beta blockers lower heart rate and contractility, so the patient can decompensate.Monitor for worsening heart failure signs and symptoms and for fluid accumulation (weight).CardiovascularL9
slide 58
Beta blockers in heart failure
carvedilol, metoprolol succinate, bisoprololBlack box
Added background: beta blockers must not be stopped abruptly (rebound angina, arrhythmia, myocardial infarction). Metoprolol carries an FDA boxed warning (black box) for abrupt cessation; carvedilol and bisoprolol carry no boxed warning but give the same caution.Never stop abruptly. Ask about missed doses and running out of medicine.CardiovascularL9
slide 58
Digoxin
Digoxin
cardiac glycoside
Gastrointestinal: anorexia and nausea.Check a digoxin level and electrolytes when nausea or anorexia appears in a patient taking digoxin.GastrointestinalL9
slide 68
Digoxin
cardiac glycoside
Visual disturbances: blurred vision, photophobia, xanthopsia (yellow-green tinge) and yellow-green halos or shining lights around objects.Ask every patient on digoxin about visual change; yellow-green halos should prompt a drug level right away.SensoryL9
slide 68
Digoxin
cardiac glycoside
Central nervous system: delirium, fatigue, confusion, dizziness and abnormal dreams.Suspect toxicity in an older patient with new confusion or fatigue; check the level.NeurologicL9
slide 69
Digoxin
cardiac glycoside
Cardiac: nodal slowing with a longer PR interval and shorter QT interval, ST-segment depression, bradycardia and digoxin-induced afterdepolarizations. Almost any arrhythmia can occur, including premature ventricular beats.Monitor pulse and the electrocardiogram; bradycardia and heart block are classic toxic findings.CardiovascularL9
slide 70
Digoxin
cardiac glycoside
Toxicity risk rises with low potassium, low magnesium and high calcium. Added background: digoxin has a narrow therapeutic window, and kidney impairment also raises toxicity risk because digoxin is cleared by the kidneys.Drug levels are checked for digoxin; keep potassium and magnesium normal.ToxicityL9
slide 65
Other heart failure drugs
Phosphodiesterase (type III) inhibitors
milrinone, inamrinone
Thrombocytopenia (less with milrinone) and ventricular arrhythmias.Monitor platelet count and cardiac rhythm during infusion.Hematologic / CardiovascularL9
slide 76
Phosphodiesterase (type III) inhibitors
milrinone, inamrinone
Long-term use raises mortality and morbidity compared with placebo.Used only short term in hospital.CardiovascularL9
slide 76
Ivabradine
hyperpolarization-activated channel blocker
Increased risk of atrial fibrillation and symptomatic bradycardia.Monitor heart rate and rhythm; report palpitations or dizziness.CardiovascularL9
slide 80
Ivabradine
hyperpolarization-activated channel blocker
Visual impairment (phosphenes): a transient brightness in a limited area of the visual field, halos or multiple images, from an effect on retinal photoreceptors (retinal persistency). It can resolve on its own.Warn about driving at night or in changing light; usually resolves.SensoryL9
slide 80
Sacubitril-valsartan
neprilysin inhibitor with an angiotensin receptor blocker
The most common adverse effects: hypotension, hyperkalemia, cough and renal insufficiency.Check blood pressure, potassium and kidney function.Cardiovascular / Electrolytes / RenalL9
slide 81
Sacubitril-valsartan
neprilysin inhibitor with an angiotensin receptor blockerBlack box
Added background: sacubitril-valsartan carries an FDA boxed warning (black box) for fetal toxicity.Confirm the patient is not pregnant; counsel on contraception.Reproductive / FetalL9
slide 81
Sodium-glucose cotransporter 2 (SGLT2) inhibitors
dapagliflozin, empagliflozin
Hypotension (blood volume falls as sugar and fluid are passed in the urine) and fungal infections of the genital and urinary tract.Check blood pressure and volume status; ask about genital itching, discharge and urinary symptoms.Cardiovascular / GenitourinaryL9
slide 82

Lecture 10 — Antiarrhythmic Drugs 31 entries

Drug or classSide effectsMonitoring & what to watchSystemSource
Principles and classification
All antiarrhythmics
proarrhythmia
All antiarrhythmics may induce arrhythmias.Understand the mechanism and weigh the goal (termination or prevention) against the risk; remove precipitating factors first.CardiovascularL10
slide 3
Class IA: quinidine, procainamide, disopyramide
Quinidine
class IA
Nausea, vomiting and diarrhea (30 to 50 percent).The most common reason the drug is poorly tolerated.GastrointestinalL10
slide 11
Quinidine
class IABlack box
Arrhythmias (ventricular and atrial), quinidine sudden death, torsades de pointes (2 to 8 percent). Added background (not on the slides): quinidine carries a Food and Drug Administration (FDA) boxed warning for increased mortality when it is used for arrhythmias that are not life-threatening.Watch the rhythm and the QT interval; magnesium sulfate is the treatment of torsades.CardiovascularL10
slide 11
Quinidine
class IA
Hypotension (alpha blockade at higher doses) and anticholinergic effects.Blood pressure.Cardiovascular / AutonomicL10
slide 11
Quinidine
class IA
Thrombocytopenia (may be fatal); immunological reactions.Platelet count; report bruising or bleeding.Blood / ImmuneL10
slide 11
Quinidine
class IA
Cinchonism: tinnitus, dizziness, blurred vision.Ask about ringing in the ears and vision.Nervous system / Ear and eyeL10
slide 11
Procainamide
class IA
Hypotension, slowing of conduction, nausea, torsades de pointes.Blood pressure and the rhythm. Intravenous use is better tolerated than quinidine; oral use is poorly tolerated long term.Cardiovascular / GastrointestinalL10
slide 13
Procainamide
class IABlack box
Lupus-like syndrome (25 to 50 percent), more often in slow acetylators. Added background (not on the slides): procainamide carries an FDA boxed warning for a positive antinuclear antibody test, with or without a lupus-like syndrome.Acetylator status matters: slow acetylators accumulate the drug; fast acetylators make more of the active metabolite (N-acetylprocainamide, NAPA).ImmuneL10
slide 13
Procainamide
class IABlack box
Bone marrow suppression (0.2 percent). Added background (not on the slides): the same boxed warning covers blood dyscrasias such as agranulocytosis.Blood counts.BloodL10
slide 13
Disopyramide
class IA
Hypotension, antimuscarinic effects, conduction disturbances, torsades de pointes.Blood pressure and the rhythm; its anticholinergic actions are stronger than quinidine's.Cardiovascular / AutonomicL10
slide 15
Disopyramide
class IA
Congestive heart failure from decreased contractility (a negative inotropic effect).Watch for signs of heart failure.CardiovascularL10
slide 15
Class IB: lidocaine
Lidocaine
class IB
Central nervous system toxicity: drowsiness, confusion, restlessness, muscle twitches, seizures; nystagmus is an early sign of toxicity.Look for nystagmus as the first sign of toxicity.Nervous systemL10
slide 19
Lidocaine
class IB
Hypersensitivity; increases atrioventricular conduction.Allergy history.Immune / CardiovascularL10
slide 19
Class IC: flecainide, propafenone
Flecainide
class ICBlack box
Increased mortality after myocardial infarction; ventricular tachycardia resistant to treatment. Added background (not on the slides): flecainide carries an FDA boxed warning, from the Cardiac Arrhythmia Suppression Trial, for excess mortality or nonfatal cardiac arrest after myocardial infarction, and for proarrhythmic effects.Use only without significant structural damage to the heart.CardiovascularL10
slide 23
Flecainide
class IC
Blurred vision, tremor, bronchospasm, seizures, thrombocytopenia.Breathing in patients with asthma; platelet count.Nervous system / Respiratory / BloodL10
slide 23
Propafenone
class ICBlack box
Proarrhythmic. Added background (not on the slides): propafenone carries the same FDA boxed warning for mortality from the Cardiac Arrhythmia Suppression Trial.The rhythm.CardiovascularL10
slide 24
Propafenone
class IC
Dizziness, blurred vision, bradycardia; bronchospasm (beta-adrenergic blockade); agranulocytosis, anemia, thrombocytopenia; worsens heart failure.Heart rate, breathing and blood counts.Cardiovascular / Respiratory / BloodL10
slide 24
Class II: beta blockers
Propranolol
class II; nonselective
Heart failure, heart block, hypotension, bronchospasm; digitalis toxicity. Hyperglycemia is also listed (see the study guide on the glucose point).Heart rate, blood pressure, breathing; signs of heart failure.Cardiovascular / RespiratoryL10
slide 28
Metoprolol, acebutolol
class II; beta-1 selective
Less bronchospasm than propranolol; congestive heart failure; central nervous system sedation and fatigue.Tiredness and sedation; signs of heart failure.Nervous system / CardiovascularL10
slide 29
Class III: amiodarone, dofetilide, sotalol
Amiodarone
class IIIBlack box
Pneumonitis and pulmonary fibrosis (potentially fatal). Added background (not on the slides): amiodarone carries an FDA boxed warning for pulmonary toxicity, hepatic injury and worsened arrhythmia, and is reserved for life-threatening arrhythmias.Ask about cough and breathlessness.RespiratoryL10
slide 33
Amiodarone
class IIIBlack box
Hepatic dysfunction. Added background (not on the slides): part of the same boxed warning (hepatic injury).Liver tests.LiverL10
slide 33
Amiodarone
class III
Thyroid abnormalities (hyperthyroidism or hypothyroidism): amiodarone is an analog of thyroid hormone.Thyroid function.EndocrineL10
slide 33
Amiodarone
class III
Blue-gray skin color, photosensitivity; corneal deposits.Sun protection; eye checks.Skin / EyeL10
slide 33
Amiodarone
class III
Hypotension; neurotoxicity, neuropathy, muscle weakness, ataxia.Blood pressure; gait and strength.Cardiovascular / Nervous systemL10
slide 33
Dofetilide
class IIIBlack box
Torsades de pointes (1 to 3 percent); marked QT prolongation. Added background (not on the slides): dofetilide carries an FDA boxed warning: it must be started in a facility with creatinine clearance calculated and continuous electrocardiogram monitoring.QT interval; kidney function (it is mainly eliminated unchanged by the kidneys). Prescribing is limited to those with special training.CardiovascularL10
slide 34
Sotalol
class III with beta-blocking activityBlack box
Torsades de pointes; bronchospasm; beta-blocking effects. Added background (not on the slides): sotalol carries an FDA boxed warning: start it where the electrocardiogram can be monitored, because of QT prolongation and torsades de pointes.QT interval; breathing.Cardiovascular / RespiratoryL10
slide 36
Class IV: verapamil, diltiazem
Verapamil, diltiazem
class IV
Hypotension, edema.Blood pressure and ankle swelling; liver function (hepatic metabolism).CardiovascularL10
slide 39
Miscellaneous: adenosine, digoxin, magnesium sulfate
Adenosine
miscellaneous
Flushing (20 percent), shortness of breath, burning in the chest; it may stop the heart for 2 to 3 seconds.Continuous rhythm monitoring while it is given; effects pass quickly (half-life about 10 seconds).Skin / Respiratory / CardiovascularL10
slide 42
Digoxin
miscellaneous
Nausea, vomiting, diarrhea, anorexia.Gastrointestinal symptoms are often the first complaint.GastrointestinalL10
slide 44
Digoxin
miscellaneous
Central nervous system: confusion, delirium, headache, seizures, visual disturbances. It can also induce heart block.Mental status and vision; heart rate and atrioventricular conduction.Nervous system / Eye / CardiovascularL10
slide 44
Magnesium sulfate
miscellaneous
Bradycardia, flushing, headache; respiratory paralysis.Heart rate and breathing.Cardiovascular / RespiratoryL10
slide 45

Lecture 11 — Drugs for Pulmonary Infections, Asthma and Chronic Obstructive Pulmonary Disease 38 entries

Drug or classSide effectsMonitoring & what to watchSystemSource
Acute bronchitis
Antihistamines, sympathomimetics
in acute bronchitis
Dehydrate bronchial secretions; may prolong symptoms.Possibly avoid them in acute bronchitis.RespiratoryL11
slide 7
Antipseudomonal agents, aminoglycosides, vancomycin and linezolid
Imipenem/cilastatin
carbapenem
Seizures.Use with caution in a seizure history; meropenem carries less seizure risk.Nervous systemL11
slide 25
Aminoglycosides
gentamicin, tobramycin, amikacin
Ototoxicity and nephrotoxicity.Drug levels guide dose and frequency; highly dependent on renal function.Ear / KidneyL11
slide 28
Vancomycin
glycopeptide
Ototoxicity; nephrotoxic, especially with other nephrotoxins.Trough before the third or fourth dose (steady state); renal adjustment.Ear / KidneyL11
slide 29
Nosocomial (hospital-acquired) pneumonia
Antibiotic therapy
nosocomial pneumonia
Complications: C. difficile colitis, empyema or lung abscess (one of the three reasons therapy fails, with wrong therapy and wrong diagnosis).Scale back coverage as cultures return.Gastrointestinal / RespiratoryL11
slide 31
Tuberculosis drugs
Isoniazid
tuberculosis
Peripheral neuritis from pyridoxine deficiency.Give pyridoxine (vitamin B6).Nervous systemL11
slide 39
Isoniazid
tuberculosis
Hepatitis, increased in alcoholics and with age.Ask about alcohol use; liver tests, especially in older patients.LiverL11
slide 39
Isoniazid
tuberculosis
Allergic reactions: a lupus-like syndrome.Listed as an allergic reaction to isoniazid.ImmuneL11
slide 39
Isoniazid
tuberculosis
Central nervous system: seizures, euphoria, psychosis, memory impairment.It is well absorbed and enters the central nervous system.Nervous systemL11
slide 39
Rifampin
tuberculosis
Orange secretions: tears, sweat, urine.Warn the patient in advance.Skin / SecretionsL11
slide 42
Rifampin
tuberculosis
Induces cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP3A4), lowering anticoagulants, contraceptives, chloramphenicol, digoxin, ketoconazole and theophylline.Review every other drug the patient takes: contraceptives and anticoagulants are on the list.Drug interactionsL11
slide 42
Rifampin
tuberculosis
Jaundice and hepatitis, a concern in chronic liver disease.Liver tests.LiverL11
slide 42
Rifampin
tuberculosis
Hypersensitivity: a flu-like syndrome in 20 percent of patients; gastrointestinal disturbances.Tell the patient it can happen.Immune / GastrointestinalL11
slide 42
Ethambutol
tuberculosis
Visual disturbances: decreased red-green discrimination and decreased visual acuity.Ask about vision and color perception.EyeL11
slide 44
Ethambutol
tuberculosis
Increased uric acid levels.75 percent is excreted unchanged: adjust in renal disease.MetabolicL11
slide 44
Pyrazinamide
tuberculosis
Hepatitis (15 percent).Monitor liver enzymes; given for the first two months only to limit liver toxicity.LiverL11
slide 45
Pyrazinamide
tuberculosis
Inhibits uric acid excretion: every patient becomes hyperuricemic.Ask about gout symptoms.MetabolicL11
slide 45
Streptomycin
second-line tuberculosis; not tested
Auditory and vestibular toxicity.Hearing and balance.EarL11
slide 46
Aminosalicylic acid
second-line tuberculosis; not tested
Gastrointestinal problems.Ask about stomach upset.GastrointestinalL11
slide 46
Cycloserine
second-line tuberculosis; not tested
Central nervous system: psychosis, seizures.Watch mood, behavior and for seizures.Nervous systemL11
slide 46
Anaphylaxis
Epinephrine
anaphylaxis
Anxiety, hypertension, tachycardia, nausea and vomiting, diaphoresis.Intramuscular is preferred unless the patient is coding.CardiovascularL11
slide 52
Epinephrine
overdose
Overdose: cerebrovascular hemorrhage, myocardial infarction, pulmonary edema.Two concentrations exist and differ tenfold: confirm which is drawn up.Cardiovascular / Nervous systemL11
slide 52
Albuterol
anaphylaxis
Anxiousness, tremor, tachycardia.Expected with a beta-2 agonist.Cardiovascular / Nervous systemL11
slide 54
Asthma: quick relief and bronchodilators
Beta-2 agonists
albuterol, levalbuterol, formoterol, salmeterol
Tachycardia, hypotension, headache, dizziness, insomnia, tremors, hyperglycemia.Increased heart rate and tremor are the expected ones; overuse of the short-acting drug means poor control.Cardiovascular / MetabolicL11
slide 71
Theophylline
methylxanthine
Arrhythmias, convulsions, headaches, nausea, insomnia, heartburn; it stimulates gastric acid, has diuretic effects and relaxes smooth muscle.Narrow therapeutic index: monitor plasma levels. As levels rise: nausea, vomiting and cardiac effects first, then seizures and arrhythmias. (The slides give level bands; their units differ between the two slides.)Cardiovascular / Nervous system / GastrointestinalL11
slide 82
Anticholinergics
ipratropium, tiotropium
Blind as a bat (blurry vision, mydriasis), mad as a hatter (hallucinations, delirium, memory loss, psychosis), red as a beet (flushing), hot as Hades (fever, hyperthermia), dry as a bone (dry mouth, dry eyes); the bowel and bladder lose their tone (constipation, urinary retention); the heart runs alone (tachycardia, hypertension).Teach the patient the dry mouth, blurred vision and urinary retention to report.AutonomicL11
slide 87
Asthma: long-term controllers and systemic steroids
Inhaled corticosteroids
controllers
Oral candidiasis (thrush).Look in the mouth at follow-up.Mouth / InfectionL11
slide 73
Inhaled corticosteroids
controllers
Growth suppression in children (high dose); immune inhibition (systemic action).Track growth in children on high doses.Endocrine / ImmuneL11
slide 73
Montelukast
leukotriene receptor antagonist
Side effects listed as minimal and well tolerated. Current labeling differs: a FDA (Food and Drug Administration) boxed warning (2020) for serious neuropsychiatric events such as agitation, depression and suicidal thoughts.Ask about mood and behavior changes.Nervous systemL11
slide 75
Omalizumab
anti-immunoglobulin EBlack box
Anaphylaxis (0.1 percent). Added background (not on the slides): also a FDA (Food and Drug Administration) boxed warning; the slides list anaphylaxis among its adverse effects.Watch the patient after each injection.ImmuneL11
slide 79
Omalizumab
anti-immunoglobulin E
Gastrointestinal disturbances; neutralizing antibodies may develop; secondary malignancies; urticaria (0.1 percent); injection-site pain; bruising.Similar profile for mepolizumab, benralizumab, reslizumab and dupilumab.Immune / Gastrointestinal / SkinL11
slide 79
Systemic corticosteroids
prednisone and others
Adrenal suppression. The general rule given: taper if the course lasts more than 5 days. References differ on the cutoff: many taper only after longer courses.Do not stop a long course abruptly.EndocrineL11
slide 89
Systemic corticosteroids
prednisone and others
Growth suppression, dermal thinning, hypertension, hyperglycemia, altered mood or mental status, muscle weakness (steroid myopathy), immunosuppression.The reason systemic steroids are kept for exacerbations: most potent, limited by side effects.Endocrine / Metabolic / MusculoskeletalL11
slide 89
Inhaler devices, technique and status asthmaticus
Nebulizer
device
A bigger dose is given overall, which may lead to more side effects.Clean regularly to prevent microbial growth.DeviceL11
slide 92
Ketamine
status asthmaticus, if intubated
Emergence phenomenon, hypertension, tachycardia, vomiting.Used only once the patient is intubated.Nervous system / CardiovascularL11
slide 99
Chronic obstructive pulmonary disease, smoking cessation and vaccines
Nicotine replacement
patch, gum, spray, inhaler
Tachyarrhythmias and hypertension.Caution in patients with cardiovascular problems.CardiovascularL11
slide 106
Varenicline
smoking cessation
Nausea, sleep disturbance, headache.Start one week before the quit date.Gastrointestinal / Nervous systemL11
slide 107
Varenicline
smoking cessationBlack box
Black box warning: neuropsychiatric events (depression, suicidal ideation). Current labeling differs: the FDA (Food and Drug Administration) removed this boxed warning in 2016; neuropsychiatric events stay in the warnings.Ask about mood and suicidal thoughts at each visit.PsychiatricL11
slide 107